Activated protein C protects against diabetic nephropathy by inhibiting endothelial and podocyte apoptosis

Publikation: Beitrag in FachzeitschriftForschungsartikelBeigetragenBegutachtung

Beitragende

  • Berend Isermann - , Universität Heidelberg (Autor:in)
  • Ilya A Vinnikov - (Autor:in)
  • Thati Madhusudhan - , Otto-von-Guericke-Universität Magdeburg, Johannes Gutenberg-Universität Mainz (Autor:in)
  • Stefanie Herzog - (Autor:in)
  • Muhammed Kashif - (Autor:in)
  • Janusch Blautzik - (Autor:in)
  • Marcus A F Corat - (Autor:in)
  • Martin Zeier - (Autor:in)
  • Erwin Blessing - (Autor:in)
  • Jun Oh - (Autor:in)
  • Bruce Gerlitz - (Autor:in)
  • David T Berg - (Autor:in)
  • Brian W Grinnell - (Autor:in)
  • Triantafyllos Chavakis - , Institut für Klinische Chemie und Laboratoriumsmedizin (Autor:in)
  • Charles T. Esmon - , University of Oklahoma (Autor:in)
  • Hartmut Weiler - (Autor:in)
  • Angelika Bierhaus - , Universität Heidelberg (Autor:in)
  • Peter P. Nawroth - , Universität Heidelberg (Autor:in)

Abstract

Data providing direct evidence for a causative link between endothelial dysfunction, microvascular disease and diabetic end-organ damage are scarce. Here we show that activated protein C (APC) formation, which is regulated by endothelial thrombomodulin, is reduced in diabetic mice and causally linked to nephropathy. Thrombomodulin-dependent APC formation mediates cytoprotection in diabetic nephropathy by inhibiting glomerular apoptosis. APC prevents glucose-induced apoptosis in endothelial cells and podocytes, the cellular components of the glomerular filtration barrier. APC modulates the mitochondrial apoptosis pathway via the protease-activated receptor PAR-1 and the endothelial protein C receptor EPCR in glucose-stressed cells. These experiments establish a new pathway, in which hyperglycemia impairs endothelial thrombomodulin-dependent APC formation. Loss of thrombomodulin-dependent APC formation interrupts cross-talk between the vascular compartment and podocytes, causing glomerular apoptosis and diabetic nephropathy. Conversely, maintaining high APC levels during long-term diabetes protects against diabetic nephropathy.

Details

OriginalspracheEnglisch
FachzeitschriftNature Medicine
PublikationsstatusVeröffentlicht - Nov. 2007
Peer-Review-StatusJa

Externe IDs

PubMed 17982464
Scopus 35948934636

Schlagworte